Bacil Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

6.53

6.53

6.53

6.53

6.53

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-5.43

-5.30

-5.14

-5.14

-4.62

Loan funds

Secured loans

0.02

0.03

0.18

0.17

0.10

Unsecured loans

-

-

-

-

-

Total

1.12

1.26

1.57

1.56

2.01

Uses of funds

Fixed assets

Gross block

0.06

0.06

0.06

0.06

0.06

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

0.05

0.05

0.04

0.04

0.03

Net block

0.01

0.01

0.01

0.02

0.03

Capital work-in-progress

-

-

-

-

-

Investments

0.43

0.31

0.37

0.43

0.96

Net current assets

Current assets, loans & advances

0.69

0.95

3.70

3.66

3.57

Less : current liabilities & provisions

0.01

0.01

2.52

2.55

2.55

Total net current assets

0.69

0.93

1.18

1.11

1.02

Miscellaneous expenses not written

-

-

-

-

-

Total

1.12

1.26

1.57

1.56

2.01

Notes:

Book value of unquoted investments

0.43

0.31

0.37

0.43

0.55

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

58.90

58.90

58.90

58.90

58.90